Literature DB >> 17361383

Cephalalgiaphobia: a possible specific phobia of illness.

Mario F P Peres1, Juliane P P Mercante, Vera Z Guendler, Felipe Corchs, Marcio A Bernik, Eliova Zukerman, Stephen D Silberstein.   

Abstract

Psychiatric comorbidity, mainly anxiety and depression, are common in chronic migraine (CM). Phobias are reported by half of CM patients. Phobic avoidance associated with fear of headache or migraine attack has never been adequately described. We describe 12 migraine patients with particular phobic-avoidant behaviours related to their headache attacks, which we classified as a specific illness phobia, coined as cephalalgiaphobia. All patients were women, mean age 42, and all had a migraine diagnosis (11 CM, all overused acute medications). Patients had either a phobia of a headache attack during a pain-free state or a phobia of pain worsening during mild headache episodes. Patients overused acute medication as phobic avoidance. It is a significant problem, associated with distress and impairment, interfering with medical care. Cephalalgiaphobia is a possible specific phobia of illness, possibly linked to progression of migraine to CM and to acute medication overuse headache.

Entities:  

Mesh:

Year:  2007        PMID: 17361383      PMCID: PMC3476114          DOI: 10.1007/s10194-007-0361-3

Source DB:  PubMed          Journal:  J Headache Pain        ISSN: 1129-2369            Impact factor:   7.277


  18 in total

1.  Cervico-cephalalgiaphobia: a subtype of phobia in patients with cervicogenic headache and neck pain? A pilot study.

Authors:  Rob A B Oostendorp; Hans Elvers; Emilia Mikolajewska; Nathalie Roussel; Emiel van Trijffel; Han Samwel; Jo Nijs; William Duquet
Journal:  J Man Manip Ther       Date:  2016-09

2.  Clinical significance of osmophobia and its effect on quality of life in people with migraine.

Authors:  Emine Meşe Pekdemir; Nermin Tanik
Journal:  Acta Neurol Belg       Date:  2022-07-21       Impact factor: 2.471

Review 3.  Medication overuse headache in children and adolescents.

Authors:  Matteo Chiappedi; Umberto Balottin
Journal:  Curr Pain Headache Rep       Date:  2014-04

4.  Self-help group and medication overuse headache: preliminary data.

Authors:  Elisa Sancisi; Marialuisa Rausa; Stefano Zanigni; Sabina Cevoli; Andrea Norcini Pala; Marianna Nicodemo; Daniela Grimaldi; Pasquale Montagna; Pietro Cortelli; Giulia Pierangeli
Journal:  Neurol Sci       Date:  2009-09-19       Impact factor: 3.307

Review 5.  Triggers, Protectors, and Predictors in Episodic Migraine.

Authors:  Michael J Marmura
Journal:  Curr Pain Headache Rep       Date:  2018-10-05

Review 6.  Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life.

Authors:  Dawn C Buse; Marcia F T Rupnow; Richard B Lipton
Journal:  Mayo Clin Proc       Date:  2009-05       Impact factor: 7.616

7.  Measuring the impact of migraine for evaluating outcomes of preventive treatments for migraine headaches.

Authors:  Sally Mannix; Anne Skalicky; Dawn C Buse; Pooja Desai; Sandhya Sapra; Brian Ortmeier; Katherine Widnell; Asha Hareendran
Journal:  Health Qual Life Outcomes       Date:  2016-10-06       Impact factor: 3.186

Review 8.  Acute and Preventive Management of Migraine during Menstruation and Menopause.

Authors:  Raffaele Ornello; Eleonora De Matteis; Chiara Di Felice; Valeria Caponnetto; Francesca Pistoia; Simona Sacco
Journal:  J Clin Med       Date:  2021-05-24       Impact factor: 4.241

9.  Cephalalgiaphobia as a feature of high-frequency migraine: a pilot study.

Authors:  Giulia Giannini; Stefano Zanigni; Daniela Grimaldi; Roberto Melotti; Giulia Pierangeli; Pietro Cortelli; Sabina Cevoli
Journal:  J Headache Pain       Date:  2013-06-10       Impact factor: 7.277

10.  Biofeedback in the prophylactic treatment of medication overuse headache: a pilot randomized controlled trial.

Authors:  Marialuisa Rausa; Daniela Palomba; Sabina Cevoli; Luana Lazzerini; Elisa Sancisi; Pietro Cortelli; Giulia Pierangeli
Journal:  J Headache Pain       Date:  2016-09-22       Impact factor: 7.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.